Thymosin ␤ 4 (t␤ 4 ) belongs to a large family of highly conserved, small bioactive molecules (1, 2) . It is the most abundant, most well studied, and likely the most biologically active member of the family, present in all cells except red blood cells and in all body fluid studied (saliva, tears, blood, plasma, wound fluid). Since T␤ 4 lacks a secretion signal, it is speculated that its presence in body fluids is due to damaged cells. It is localized both in the cytoplasm and in the cell nucleus. Since its isolation from the thymus gland as a heat-stable component of fraction 5 in 1966 (3), when it was shown to have "hormonelike" properties, it has been found to have considerable and broad biological activities ( Fig. 1) , which are unexpected for such a small protein. It was initially described in 1991 as an actin-binding protein, and a major actin-binding site is localized in amino acid residues 17-22 (2, 4) . It was shown subsequently in 1997 to promote cell migration (5) . Recently, it has been shown that T␤ 4 binding to actin monomer (G-actin) coordinates actin polymerization with metalloproteinase synthesis to promote cell motility (6) . At the leading edge of the migrating endothelial cells, T␤ 4 has reduced interaction with G-actin, which allows actin to be available for filament assembly. T␤ 4 is present in and promotes pseudopodia-like extension in tumor cells (7) , and these structures require PI3 kinase and the Rho signaling pathway. This finding may describe one mechanism by which T␤ 4 promotes tumor cell migration and invasion (8) . It also may partly explain the ability of T␤ 4 to promote cell adhesion (6, 9) .
Migration is an important process in development, repair, and certain pathologies. Migration is also important in the process of angiogenesis, and T␤ 4 has been shown to promote angiogenesis (9, 10) in many tissue sites, with the exception of the cornea. It promotes dermal and ocular repair in part due to its potent chemotactic activity associated with the rapid entry of cells into the wound (1, (11) (12) (13) (14) . It also promotes the migration of various other cells, including stem cells from the bulge region of hair follicles, resulting in increased hair growth; tumor cells, resulting in increased metastasis; and embryonic progenitor cells from cardiac tissue, resulting in the formation of new vessels (8, 15, 16, 17) . T␤ 4 upregulates metalloproteinase activity, which is important in cell migration, tissue repair, and tumor metastasis (6, 18, 19) . It promotes NK cell engulfment and stablin-2-mediated cytotoxicity, which are important in repair processes (20, 21) . Likewise, the antiapoptotic activity of T␤ 4 results in cell survival after injury, and thus affects repair by an additional mechanism, i.e., preventing cell loss (22, 23) . The ability of T␤ 4 to block apoptosis and down-regulate inflammatory cytokines may explain its antiinflammatory activity. In vitro, down-regulation of T␤ 4 with a gene-silencing approach decreases cell survival and increases hypoxia-induced apoptosis. T␤ 4 also increases oxidative enzymes and protects cells and tissues from oxidative damage (24) . In the case of peroxide damage, it reduces caspase 9 activation and intracellular ROS (reactive oxygen species) levels, and thus increases cell viability. The expression of manganese superoxide dismutases (SOD) and copper/zinc SOD increased along with increased catalase, thereby providing better protection from cell damage and better survival. T␤ 4 is reduced in both human and animal blood after LPS administration and during septic shock, and its administration to animals treated with LPS significantly reduces lethality and inflammatory mediators in endotoxin-induced septic shock (25) . Most recently, increased apoptosis in patients with septic shock and in animals receiving LPS was shown to play a key role in the high mortality observed (26) , suggesting a potential therapeutic role for T␤ 4 in sepsis or other types of widespread injury such as large burns.
A number of additional proteins that are downstream biological effectors appear to be up-regulated by T␤ 4 . For example, laminin-5 is up-regulated by T␤ 4 both in vitro and in vivo (22, 28) . Laminin-5 is important in cell migration and in cell-cell contacts, and thus in tissue integrity. The up-regulation of TGF␤ by T␤ 4 is likely a key mediator of the accelerated collagen deposition seen in wounds treated with T␤ 4 (11, 27, 29) . T␤ 4 stimulates many factors important in angiogenesis, such as VEGF synthesis, and this is important for both angiogenesis and tumor metastasis (8, 30) . T␤ 4 also up-regulates vascular endothelial (VE)-cadherin, which is important in vascular development, stabilization, and cell survival, and angiopoietin-2, which regulates vessel outgrowth, remodeling, and maturation (30) . Von Willebrand factor, which is associated with adverse cardiovascular events and endothelial cell dysfunction, is down-regulated by T␤ 4 . Interestingly, terminal deoxynucleotidyl transferase is induced by T␤ 4 , and this may explain, in part, its antiapoptotic activity (31, 32) . Many of the molecules regulated by T␤ 4 are important in wound repair and define possible mechanisms by which this protein has so many different effects in the repair process.
T␤ 4 is present in the brain and localized in growing neurites in the cerebellar granule cells (33) . It is induced 10-fold by PC12 cells when they are exposed to NGF and bFGF, suggesting a role in neurite outgrowth related to the protrusion of the growing neurites (34) . T␤ 4 increases after brain ischemia injury, again suggesting a role in the repair process (35) . Finally, T␤ 4 promotes neural cell survival in part by up-regulating the protein L1, which is important for cell survival and outgrowth of cultured spinal cord neurons (36, 37) . The effect on L1 levels is dose dependent, and the response to T␤ 4 is likewise dose dependent. Thus, T␤ 4 could have therapeutic potential in repair and in regeneration of injured nerves and brain tissue. Recently, this role in neural repair has been demonstrated in an animal model of multiple sclerosis where T␤ 4 protected the brain tissue from damage and promoted functional recovery (38) . These findings suggest that T␤ 4 could be neuroprotective in additional neurological pathologies involving inflammation and scarring, including spinal cord injury (36) .
A large number of animal studies point to multiple roles of T␤ 4 in repairing injury to the eye. Most recently, several compassionate-use cases in patients with neurotrophic corneal ulcers demonstrate the efficacy of using T␤ 4 to treat eye injuries (39) . T␤ 4 has been shown in animals to promote corneal wound healing after heptanol or sodium hydroxide-induced injury (13, 14) . It acts in the eye to promote epithelial cell migration, cell-cell and cell-matrix contacts, laminin-5 production, and metalloproteinase activity (18, 27) . T␤ 4 acts to inhibit apoptosis (22) and inflammation by reducing inflammatory cell infiltration and down-regulation of a number of inflammatory cytokines and chemokines (13, 14) . One mechanism involves inhibition of NFB activation and nuclear translocation in TNF-␣-stimulated cells (40) . T␤ 4 also inhibits apoptosis and oxidative damage by up-regulation of antioxidative enzymes (24) . Thus, many of the activities of T␤ 4 protect the cells in the eye and promote repair.
T␤ 4 also has important and significant functions in heart repair, and some of the pathways defined in this process have been identified (16, 17, 23, 41) . It increases adult and embryonic myocardial and endothelial cell/vessel outgrowth from explants, migration, and survival of progenitor cells (16, 23) . The progenitor cells become activated and initiate the expression of a number of genes important in angiogenesis and epicardial activation (41) . T␤ 4 also stimulates endothelial vasculogenesis and angiogenesis of these progenitor cells (16) . Since animals with knocked-down T␤ 4 in the heart have impaired vessel development, a thin myocardium, reduced smooth muscle cell recruitment and differentiation, failed ventricular contraction, and abnormal aorta and pulmonary arteries, it is clear that T␤ 4 is important for normal heart and vessel development. It is also important in repair after injury to the heart (17, 23) . T␤ 4 forms a functional complex with PINCH and ILK (integrin-linked kinase), resulting in activation of the survival kinase Akt (protein kinase B). In heart injury after coronary ligation, T␤ 4 is endogenously increased in vivo along with increased ILK and Akt, resulting in improved cardiac function. Recombinant T␤ 4 protects posthypoxic myocytes and endothelial cells, decreases infarct size, and increases global systolic function. This could be due to the decreased inflammation and leukocyte adhesion (13, 14, 42) . Thus, T␤ 4 has a clear and positive role in cardiac development and in cardioprotection after injury, and it protects against reperfusion injury (17, 43) . It supports cardiac regeneration and survival after ischemic insult and infarction and induces new vessel growth, progenitor cell mobilization and activation, and decreased inflammation (16, 23, 44) .
Despite the extensive identification of various biological activities for T␤ 4 , little progress has been made in identifying cell surface receptors that mediate these activities. Actin has been reported on the cell surface and may serve as a receptor, but this has not been demonstrated directly (45) . Studies by Huang et al. (46) have provided evidence that T␤ 4 may act via adenosine receptors, as the researchers could block the effects of T␤ 4 in a migration model by the use of suramin, an antagonist to P 2 -receptors. Inside cells, two putative receptors have been identified, which bind to T␤ 4 and may be involved in its nuclear transport and function (47, 48) . The function of T␤ 4 in the nucleus is not understood (49) . Since actin is in the nucleus, it is tempting to speculate a structural role but without excluding a biological role in transcription as well. The hMLH1 component of the DNA mismatch repair complex binds to T␤ 4 and may serve as a nuclear import carrier (46) . In addition, the nuclear protein KU80 subunit of DNA helicase II binds to T␤ 4 and is associated with the expression of plasminogen activator inhibitor type 1 (PAI-1), which has a role in angiogenesis (48) . T␤ 4 is a multifunctional protein that has pleotropic activities important in cell survival and repair. Many of the activities observed with T␤ 4 are critical for the repair and remodeling of tissues of the eye, skin, heart, and neural system following injury. This finding suggests that T␤ 4 may aid via similar common mechanisms in the healing of additional injured tissues, such as the oral cavity, gut, and spinal cord. Progress has been made in identifying the active sites and/or domains in the molecule responsible for many but not all of these activities. 
Ac-SDKP PEPTIDE (AMINO ACID RESIDUES 1-4)
The amino-terminal peptide Ac-SDKP of T␤ 4 is normally found in serum and in other body fluids (50) . The sequence is not found in other proteins (search engine: http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl? pageϭnpsa_pattinprot.html), and a reduction in T␤ 4 by knockdown in the heart reduces serum Ac-SKDP in mice (16) . This peptide is generated by an unidentified endopeptidase and a prolyl oligopeptidase (51) . Ac-SDKP is degraded further by angiogtensin-converting enzyme (ACE), and the levels of Ac-SDKP are elevated in the serum by ACE inhibitors up to 4-to 5-fold (50 -53). Ac-SDKP has various biological activities important in repair mechanisms ( Table 1) . Many of these actions are not found in the intact T␤ 4 molecule, which suggests that this is a cryptic site that is only exposed on cleavage to the small peptide. This peptide was originally found to inhibit proliferation of pluripotent hematopoietic stem cells (54) and subsequently shown to promote angiogenesis in vitro and in vivo in various models (16, 55) . It was later shown to decrease inflammation in many models, reduce and prevent fibrosis in hypertension, and even reverse fibrosis after myocardial infarction (56 -60) . Furthermore, lymphatic cells synthesize a splice variant of T␤ 4 , which has an additional 6 amino-terminal amino acids containing a second SDKP (61). It is not clear how these sites are cleaved, but lymphocyte T␤ 4 has been reported to have more antiinflammatory activity than regular T␤ 4 . The mechanisms for the decreased inflammation appear, in part, to involve inhibition of the differentiation of bone marrow stem cells to macrophages, activation and migration of macrophages, release of the proinflammatory cytokine TNF-␣ by activated macrophages, and inhibition of lymphocyte proliferation (62, 63) . In addition, it has been reported that T␤ 4 suppresses activation of NFB, which is important in inflammatory signaling pathways (40) . This peptide reduces/prevents fibrosis in various animal models of cardiac, aortic, and renal injury ( Table  1 ). Note that stimulators of ACE activity cause increased organ fibrosis presumably due to decreased levels of Ac-SDKP (64) . Also, inhibitors of the prolyl oligopeptidase which generates Ac-SDKP increase organ fibrosis (65) . Ac-SDKP has been shown to reduce collagen synthesis in vitro consistent with its antifibrotic activity (66) . It inhibits transforming growth factor ␤ (TGF␤) activity, which is important in collagen synthesis, in part by suppressing Smad activation which blocks TGF␤ signal transduction (44, 67).
Because ACE inhibitors increase the serum levels of Ac-SDKP and improve the clinical outcome of patients with renal disease, T␤ 4 or Ac-SDKP may have use as a preventive for treating patients likely to have fibrotic problems when ACE inhibitors cannot be used, or even in conjunction with these inhibitors. Ac-SDKP also reverses fibrosis in animal models, which suggest that T␤ 4 or T␤ 4 analogues or peptides may have potential use in patients with apparent scarring diseases. Finally, patients with myocardial infarction, stroke, or spinal cord injury where permanent damage could be caused by fibrosis/scarring may be candidates for treatment with T␤ 4 or T␤ 4 -like peptides containing Ac-SDKP at very early time points. Since Ac-SDKP can be rapidly degraded and is costly to prepare synthetically, it is possible that nonpeptide Ac-SDKP mimetics/analogues may have some use in the future as therapeutics.
LKKTETQ PEPTIDE (AMINO ACID RESIDUES 17-23)
T␤ 4 is a major actin-sequestering molecule in eukaryotic cells, and LKKTET was initially reported as a major actin-sequestering site on T␤ 4 (2) . Several other residues on T␤ 4 also contribute to this important activity. An actin-binding site containing peptide with an additional amino acid, LKKTETQ, has several biological functions beyond actin-binding ( Table 2) . This peptide has been found in wound fluid (46) , which suggests that it is a naturally occurring product of T␤ 4 degradation and that it may have physiological relevance in wounds and possibly in other normal and pathological conditions. Note that it also induces mast cell exocytosis, which could be important in wound healing. In addition, mast cells may provide additional repair factors (68, 69) . This finding could be an important 
by formazan concentration. Chlorhexidine (0.0002%) was added to the basal medium in the presence or absence of T␤ 4 and derived peptides for 1 h; 100 l of culture medium (nϭ4) was added to 100 l of LDH reagent and incubated at room temperature for 20 min. OD 500 nm was read, and averages Ϯ sem were calculated. *P Յ 0.05; **P Յ 0.01; ***P Յ 0.001. function in early wound healing, which helps to accelerate the wound cascade. It promotes angiogenesis both in vitro and ex vivo (9) . Endothelial cell migration and tube formation in vitro have been demonstrated with LKKTETQ. Ex vivo, it promotes sprouting from aortic rings. Sprouting from aortic rings as well as cell adhesion are blocked by addition of soluble actin. One interpretation is that this peptide may function by binding to the actin on the cell surface (45) . It is also possible that the actin binding to the peptide blocks accessibility of the cell surface receptor for the peptide. LKKTETQ promotes wound healing in normal rats and in aged mice and appears to be as active as the parent molecule when applied topically to full thickness dermal wounds (70) . An unexpected finding was its ability also to promote hair growth when applied topically to rodent skin via activation of existing follicles. Thus, LKKTETQ is a major biologically active site for T␤ 4 and the activities with the exception of angiogenesis appear distinct from those of Ac-SDKP.
PEPTIDE 1-15 (AcSDKPDMAEIEKFDKS)
Several other T␤ 4 -derived peptides have been screened for biological activity. One encompassing aa 1-15 has been found to be a major site for protection from toxicity and for antiapoptotic activity. Even though it contains the Ac-SDKP site, it does not appear to contain all of the antiinflammatory activity, which suggests that Ac-SDKP is even cryptic in this small peptide and may require cleavage to 4 aa for activity. This peptide protects cells from chlorhexidine (which is active against bacteria, yeast, and fungi) by altering cell membrane integrity. Chlorhexidine is extremely toxic to keratinoyctes. Chlorhexidine induces apoptosis with L929 cells at low (0.002%) and necrosis at higher concentrations (0.016%). Cytotoxicity is measured based on cellular release into the culture medium of lactate dehydrogenase. We tested the toxicity (release of lactate dehydrogenase) of 0.002% chlorhexidine on human dermal fibroblasts in the presence of various T␤ 4 -derived peptides (Fig. 2) . T␤ 4 protected the cells from the toxic effects of this reagent, while the other peptides tested failed to protect the cells, with the exception of peptide 1-15, which was protective in both the acetylated and unacetylated forms (Fig. 2) . Not all of the peptides were overlapping, so an additional site might exist. It is also interesting to note that peptide contained within this region, aa 7-15, was also inactive. The protective effect was observed after 1, 2, and 3 h of chlorhexidine treatment (Table 3) . Using benzalkonium chloride, another toxic agent, we tested the effect of various doses of peptide 1-15 ( Fig. 3) and found 0.01 g/ml and higher amounts being protective, but 0.001 g/ml was inactive. The toxic effects of concentrations of 0.005 and 0.002% chlorhexidine could be blocked by peptide 1-15, but at a higher concentration (0.010%), this toxic effect could not be blocked by the peptide. Similar protection from toxicity was obtained with peptide 1-15 when human dermal fibroblasts were 4 and various derived and unacetylated peptides on chlorhexidine-induced apoptosis. Human dermal fibroblasts were grown to 80% and then treated with 0.002% chlorhexidine in the presence or absence of T␤ 4 and derived peptides for 2 h. APO Percentage dye was added to the cultures at a 1:50 dilution for an additional 30 min. A) Adobe Photoshop was used to calculate the number of red pixels in 6 digitized images for each experiment. *P Յ 0.0017; t test. B) Excess dyes were washed from cells, and digital images were captured. Cells with red dye are undergoing apoptosis.
tested with hydrogen peroxide (1%) and with benzalkonium chloride (0.01%) (Fig. 3) . Neither T␤ 4 nor peptide 1-15 could block 10% ethanol toxicity. These data show that peptide 1-15 contains a site that protects cells from the cytotoxic effects of various reagents.
Various peptides were also tested for their ability to protect dermal fibroblasts from chlorhexidine-induced apoptosis (Fig. 4) . Only T␤ 4 and peptide 1-15 were able to block apoptosis. These data demonstrate a major cytoprotective site in the first 15 aa of T␤ 4 . This site has distinct activity from the other two sites described above. We conclude that the peptide encompassing aa 1-15 is an important site for cell survival.
SUMMARY
It is surprising that a molecule as small as T␤ 4 contains so many biological as well as structural functions. Many of these activities are localized in distinct amino acid-specific peptide sequences (Fig. 5) . At least three different active sites have been identified, including peptide 1-4, Ac-SDKP, for antiinflammation and angiogenesis; peptide 17-22, LKKTETQ, for actin binding and wound healing; and peptide 1-15 for cytotoxicity protection. While T␤ 4 has been described in the cytoplasm and nucleus, it is not clear where these peptides are localized in the cell at this time (1) . Ac-SDKP appears to be a natural cleavage product (51), but it is not known whether is cleaved from the intact molecule or from smaller fragments. The actin-binding site LKKTETQ peptide has been found in wound fluid after tryptic cleavage and may also be a naturally occurring peptide (46) . Peptide 1-15 has not previously been studied, and it is not known if it is a naturally occurring fragment or an intermediate in Ac-SDKP generation. The activity of these three sites is important physiologically as possible therapeutics, and further identification of their role in the molecule and the mechanisms for their generation should be of future interest for investigation. Other active domains likely exist. By using these T␤ 4 -derived peptides, one will further be able to sort out the pathways and genes regulated during these activities. The definition and molecular characterization of the complete domains and the active sites for these activities will hopefully lead to the development of more targeted and specific therapeutics. 
